NCT01409395View on ClinicalTrials.gov

Drug-Drug Interaction Study With Metformin and Nizatidine

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Healthy
Interventions
DRUG

Metformin and nizatidine

Subjects will be given a single oral dose of 850 mg of metformin and a single oral dose of 600 mg of nizatidine

DRUG

Metformin

Subjects will be given a single oral dose of 850 mg of metformin

Trial Locations (1)

94158

Ucsf Ctsi Crc, San Francisco

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of California, San Francisco

OTHER

NCT01409395 - Drug-Drug Interaction Study With Metformin and Nizatidine | Biotech Hunter | Biotech Hunter